Spectrum Pharmaceuticals, Inc.Equity-NMS: SPPI
Equity-NMS: SPPI
$0.88
+0.04
(7:59 pm IST)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$0.88
Open
$0.88
52W high
$3.26
1Y
5.38%
5Y
-51.87%
Shares O/S
180.09M
Market cap
158.48M
Insights
No insights found for this stock
Compare with other stock
Price
1D
PE
Market cap
About Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. Its pipeline products include ROLONTIS, Poziotinib and Anti-CD20-IFNa. ROLONTIS (eflapegrastim injection), is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia.

Poziotinib, is a pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. Anti-CD20-IFNa, is an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for treating relapsed or refractory non-Hodgkin's lymphoma (NHL) patients. .


FAQs

Can I buy Spectrum Pharmaceuticals, Inc. shares in India?
How to buy Spectrum Pharmaceuticals, Inc. shares in India?
What is the share price of Spectrum Pharmaceuticals, Inc.?
What is the Market Capitalization of Spectrum Pharmaceuticals, Inc.?
What is the PE ratio of Spectrum Pharmaceuticals, Inc.?
Is Spectrum Pharmaceuticals, Inc. a good stock to buy?
In which sector / industry does Spectrum Pharmaceuticals, Inc. operate?